These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer. Melosky B; Anderson H; Burkes RL; Chu Q; Hao D; Ho V; Ho C; Lam W; Lee CW; Leighl NB; Murray N; Sun S; Winston R; Laskin JJ J Clin Oncol; 2016 Mar; 34(8):810-5. PubMed ID: 26573073 [TBL] [Abstract][Full Text] [Related]
3. Clinical impact of minocycline on afatinib-related rash in patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Goto A; Ozawa Y; Koda K; Akahori D; Koyauchi T; Amano Y; Kakutani T; Sato Y; Hasegawa H; Matsui T; Yokomura K; Suda T Respir Investig; 2018 Mar; 56(2):179-183. PubMed ID: 29548657 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients. Yamada M; Iihara H; Fujii H; Ishihara M; Matsuhashi N; Takahashi T; Yoshida K; Itoh Y Anticancer Res; 2015 Nov; 35(11):6175-81. PubMed ID: 26504047 [TBL] [Abstract][Full Text] [Related]
5. Rash management and treatment persistence of cancer patients treated with epidermal growth factor receptor inhibitors in the Truven MarketScan Chen L; Brown J; Marmaduke DQ; Mayo C; Grau G; Lau YK; Obasaju CK Support Care Cancer; 2018 Jul; 26(7):2369-2377. PubMed ID: 29423677 [TBL] [Abstract][Full Text] [Related]
11. Drug rash, eosinophilia, and systemic symptoms syndrome: Two pediatric cases demonstrating the range of severity in presentation--A case of vancomycin-induced drug hypersensitivity mimicking toxic shock syndrome and a milder case induced by minocycline. Vinson AE; Dufort EM; Willis MD; Eberson CP; Harwell JI Pediatr Crit Care Med; 2010 Jul; 11(4):e38-43. PubMed ID: 20407399 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced hypersensitivity syndrome due to minocycline complicated by severe myocarditis. Kanno K; Sakai H; Yamada Y; Iizuka H J Dermatol; 2014 Feb; 41(2):160-2. PubMed ID: 24471460 [TBL] [Abstract][Full Text] [Related]
13. NSAIDs may prevent EGFR-TKI-related skin rash in non-small cell lung cancer patients . Iimura Y; Shimomura H; Yasu T; Imanaka K; Ogawa R; Ito A; Suzuki K; Yamaguchi G; Kawasaki N; Konaka C Int J Clin Pharmacol Ther; 2018 Nov; 56(11):551-554. PubMed ID: 30232957 [TBL] [Abstract][Full Text] [Related]
14. Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Wei X; Zhao L; Liu J; Dodel RC; Farlow MR; Du Y Neuroscience; 2005; 131(2):513-21. PubMed ID: 15708492 [TBL] [Abstract][Full Text] [Related]